Table 1.

TKIs KRAS G12C Inhibitors in Clinical Development.

Drug	Sponsor	Stage	ClinicalTrials.gov Identifier
Sotorasib	Amgen	Phase I–III	NCT04185883
Adagrasib	Mirati	Phase I–III	NCT03785249
GDC-6036	Genentech/Roche	Phase I	NCT04449874
JNJ-74699157	Janssen	Phase I	NCT04006301
D-1553	Inventis Bio	Phase I	NCT04585035